Health and Medicine in Africa
Traditional systems, colonial legacies and the vaccine push.
Full detail, evidence and debate
African health systems combine long herbal and surgical traditions with public health infrastructure built under colonial rule for export economies — and now a continental drive to manufacture medicine at home rather than wait in the queue.
- Vaccine imports
- Africa imports roughly 99% of the vaccines it uses
- PAVM target
- 60% of routine vaccines made in Africa by 2040
- Malaria deaths
- Over half a million a year, mostly African children under five
Source Mode
Show how strongly each section is supported.
Indigenous practice
Supported by archaeology, written records and peer-reviewed research with broad agreement among historians.
African therapeutic traditions were empirical, specialised and transmitted. Bunyoro surgeons in nineteenth-century Uganda performed caesarean sections with banana-wine antisepsis, cautery for haemostasis and post-operative care, and European observers recorded mothers and infants surviving routinely. West African communities practised variolation against smallpox — deliberate inoculation with material from a mild case — generations before Edward Jenner's cowpox work, and the practice crossed the Atlantic with enslaved Africans: an enslaved man named Onesimus described it to Cotton Mather in Boston, and it was used during the 1721 epidemic there. Herbalists across the continent worked with pharmacologically active plants, several of which entered global medicine, including the Madagascar periwinkle behind vincristine and vinblastine, drugs that transformed childhood leukaemia survival.
What colonial medicine was for
The broad outline is accepted but dates, numbers or details are actively argued by specialists.
Colonial health services were rarely built for the health of colonised populations. They were built to keep soldiers, administrators and labour forces functional. Hospitals clustered around ports, mines and plantations; sleeping-sickness campaigns protected the rubber and cotton economies as much as the people in them. Some campaigns were coercive, involving forced examination, mass injection with reused needles — now implicated in the spread of hepatitis C in parts of central Africa — and the resettlement of whole villages. That history explains a good deal of the vaccine hesitancy that later commentators treat as irrational, and it shaped independent states' inheritance: curative, urban, hospital-centred systems in countries whose need was preventive and rural.
Primary care and the Alma-Ata promise
Supported by archaeology, written records and peer-reviewed research with broad agreement among historians.
The 1978 Alma-Ata declaration on primary health care drew heavily on African experiments in community-based care, and post-independence states in Tanzania, Mozambique and Ghana pushed clinics, community health workers and immunisation outward from the capitals. Structural adjustment in the 1980s and 1990s cut those budgets, introduced user fees and drove trained staff abroad. Ethiopia's health extension programme, which trained tens of thousands of salaried community health workers from the early 2000s, is the clearest demonstration of what the original model could do: sharp falls in child mortality achieved without large hospital construction.
The HIV decades
Supported by archaeology, written records and peer-reviewed research with broad agreement among historians.
By the late 1990s HIV had reversed life expectancy gains across southern and eastern Africa, and antiretrovirals cost more per patient per year than most health systems spent per citizen. The response reshaped global health law and practice: Treatment Action Campaign litigation in South Africa, the 2001 Doha declaration confirming states' right to compulsory licensing, Indian generic manufacture that cut prices by more than 95%, and then PEPFAR and the Global Fund. Uganda's early prevention campaigns and Senegal's rapid response are studied as much as the failures — including South Africa's period of state AIDS denialism, which peer-reviewed modelling associates with hundreds of thousands of avoidable deaths.
The COVID lesson
Supported by archaeology, written records and peer-reviewed research with broad agreement among historians.
Africa received roughly 1% of the world's first-year COVID-19 vaccine doses while importing about 99% of all vaccines it routinely uses. Export bans and bilateral pre-purchase left African states at the back of a queue they had no way to jump. The institutional answer was fast and structural: the Africa Medical Supplies Platform for pooled procurement, the elevation of the Africa CDC, and the Partnerships for African Vaccine Manufacturing with its 60%-by-2040 target. Afrigen in Cape Town, working as the WHO mRNA technology transfer hub, reverse-engineered an mRNA candidate and is training manufacturers from more than a dozen countries. Sustainability depends on something duller than science: guaranteed procurement, so African plants are not idle between emergencies.
The current burden
Supported by archaeology, written records and peer-reviewed research with broad agreement among historians.
Malaria still kills more than half a million people a year, the great majority African children under five, even as the RTS,S and R21 vaccines roll out alongside bed nets and seasonal chemoprevention. Tuberculosis, HIV and neglected tropical diseases remain heavy. At the same time non-communicable disease is rising quickly with urbanisation — hypertension, diabetes, road injury and cancers now sit alongside infectious disease rather than replacing it, producing a double burden on systems designed for one. Maternal mortality remains the sharpest inequity: a woman's lifetime risk of dying in childbirth differs between African countries by more than an order of magnitude, and most of that difference is attributable to skilled birth attendance and emergency obstetric access, not biology.
Genomics on African terms
Supported by archaeology, written records and peer-reviewed research with broad agreement among historians.
African populations hold more human genetic variation than the rest of the world combined, and for decades that variation was studied by foreign teams who exported samples and published elsewhere. H3Africa was built to change the terms: African-led projects, African biobanks in Uganda, Nigeria and South Africa, and data-sharing rules that keep African researchers as principal investigators. The scientific stakes are high — drug responses, sickle cell, cancer risk models and reference genomes are all distorted when they are trained mostly on European data — and so are the ethical ones, which is why consent, benefit-sharing and export rules are written into the programme rather than added afterwards.
What decides the next decade
The broad outline is accepted but dates, numbers or details are actively argued by specialists.
Three things, none of them glamorous. Health financing: most African states remain below the 15% of national budget they pledged at Abuja in 2001, and out-of-pocket payment still pushes households into poverty. Workforce: training more staff matters less than retaining them, which means salaries, equipment and career paths rather than appeals to patriotism. Manufacture: the African Medicines Agency, ratified in 2021, is meant to give the continent a single credible regulator so that locally made medicines can be approved and traded at scale under AfCFTA. Get those three right and the clinical knowledge already exists.
Sources
- H3Africa: Human Heredity and Health in AfricaAfrican source
African Academy of Sciences / NIH
https://h3africa.org/ - African Economic OutlookAfrican source
African Development Bank
https://www.afdb.org/en/knowledge - Agenda 2063: The Africa We WantAfrican source
African Union Commission · 2015
https://au.int/en/agenda2063/overview - World Population Prospects
UN Department of Economic and Social Affairs · 2024
https://population.un.org/wpp/
Follow the thread
African Science and Invention
From Nubian antibiotics to Kenyan mobile money.
Africa's scientific record runs continuously: mathematics on bone, metallurgy, medicine, astronomy, and today mobile payments, vaccine manufacture and radio astronomy. The gap is not talent or history — it is research funding, retention and the ability to turn discovery into industry at home.
ContinentalThe Youngest Continent
One in four humans will be African by 2050.
Africa's median age is around 19. Its population is projected to reach roughly 2.5 billion by 2050, and by 2100 the continent is expected to hold the world's largest working-age population — an advantage only if it is educated, healthy and employed.
ContinentalAgenda 2063
The Africa We Want, written by Africans.
The African Union's fifty-year framework, adopted in 2015 on the fiftieth anniversary of the OAU: seven aspirations, twenty goals, and a set of flagship projects delivered through successive ten-year implementation plans. It is the continent's own long-term plan for 2063 — prosperity, integration, good governance, peace, cultural identity, people-driven development, and Africa as a global player.
Continental